Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Synergetic B-cell Immunomodulation in SLE - 2nd Study. (SynBioSe-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03747159
Recruitment Status : Recruiting
First Posted : November 20, 2018
Last Update Posted : November 30, 2018
Sponsor:
Collaborators:
Dutch Kidney Foundation
GlaxoSmithKline
Information provided by (Responsible Party):
YTeng, Leiden University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : October 2023